,type,name,h_seq,l_seq
0,mouse,Abituzumab,QVQLQQSGAELAKPGASVKLSCKASGYTFTSFWMHWVKQRPGQGLEWIGYINPRSGYTEYNEIFRDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARFLGRGAMDYWGQGTSVTVSS,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLAWYQQKPDGTIKLLIYYTSKIHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTFPYTFGGGTKLEIK
1,humanized,Abituzumab,QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLEWIGYINPRSGYTEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCASFLGRGAMDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYYTSKIHSGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQGNTFPYTFGQGTKVEIK
2,mouse,Afutuzumab,QVQLQQSGPELVKPGASVKISCKASGYAFSYSWINWVKQRPGQGLEWIGRIFPGDGDTDYNGKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARNVFDGYWLVYWGQGTLVTVSA,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK
3,humanized,Afutuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS,DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK
4,mouse,Alacizumab,EVKLVESGGDLVKPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLEWVATITSGGSYTYYVDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARIGEDALDYWGQGTSVTVSS,DIQMTQSPSSLSASLGERVSLTCRASQDIAGSLNWLQQEPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYGSFPPTFGGGTKLEIK
5,humanized,Alacizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLEWVATITSGGSYTYYVDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCVRIGEDALDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIAGSLNWLQQKPGKAIKRLIYATSSLDSGVPKRFSGSRSGSDYTLTISSLQPEDFATYYCLQYGSFPPTFGQGTKVEIK
6,mouse,Alemtuzumab,DVMLVESGGGLVQPGGSLSLSCAASGFTFTDFYMNWVRQPPGKALEWLGFIRDKAKGYTTEYNPSVKGRFTILRDNSQSILYLQMNALRAEESATYYCAREGHTAAPFDYWGQGSTLTVSS,DIKLIQSQASLSASLGETVTLTCKASQNIDKYLNWYQQKQGKSPKLLVYNTNNLQTGVPSRFSGSGSGTQFSLKINSLQTEDFGNYYCLQHISRPRTFGGGTKLEIK
7,humanized,Alemtuzumab,QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIK
8,mouse,Anrukinzumab,EVQLVESGGGLVKLGGSLKLSCAASGFTFSSYAMSWVRQTPGKRLEWVASISSGGNTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARLDGYYFGFAYWGQGTLVTVSA,DIVLTQSPASLAVSLGQRATISCKASESVDNYGKSLMHWYQQKPGQPPKLLIYRASNLESGIPARFSGSGSRTDFTLTINPVEADDIATYYCQQSNEDPWTFGGGTKLEIK
9,humanized,Anrukinzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFISYAMSWVRQAPGKGLEWVASISSGGNTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLDGYYFGFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASESVDNYGKSLMHWYQQKPGKAPKLLIYRASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPWTFGGGTKVEIK
10,mouse,Atezolizumab,EVQLVESGGGLVQPGRSLKLSCAASGFTFSDSWIHWIRQAPTKGLEWVAWISPYGGSTYYADSVKGRFTIFRDVAKSTLYLQMDSLRSEDTATYYCARRHWPGGFDYWGQGVMVTVSS,DIVMTQSHKFMSTSVGDRVSITCRASQDVSTAVAWYQQKPGQSPKLLIYSASFLYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYLYHPATFGGGTKLEIK
11,humanized,Atezolizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK
12,mouse,Bapineuzumab,EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMSWVRQVPTKGLEWVTSIRSGGGRTYYSDNVKGRFTISRDNAKNTQYLQMDSLRSEDTATYYCVRYDHYSGSSDYWGQGVMVTVSS,DVVMTQTPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWLLQRPGQSPKRLIYLVSKLDSGVPDRFTGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPRTFGGGTKLEIK
13,humanized,Bapineuzumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASIRSGGGRTYYSDNVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVRYDHYSGSSDYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCKSSQSLLDSDGKTYLNWLLQKPGQSPQRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPRTFGQGTKVEIK
14,mouse,Bemarituzumab,QVQLQQSGAELVKPGASVKMSCKASGYTFTTYNVHWVKQTPGQGLEWIGSIYPDNGDTSYNQNFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGDFAYWGQGTLVTVSA,DIVMTQSHKFMSTSVGDRVSITCKASQGVSNDVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHSTTPYTFGGGTKLEIK
15,humanized,Bemarituzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYIFTTYNVHWVRQAPGQGLEWIGSIYPDNGDTSYNQNFKGRATITADKSTSTAYMELSSLRSEDTAVYYCARGDFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQGVSNDVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHSTTPYTFGQGTKLEIK
16,mouse,Benralizumab,EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVIHWVKQRPGQGLEWIGYINPYNDGTKYNERFKGKATLTSDKSSSTAYMELSSLTSEDSAVYLCGREGIRYYGLLGDYWGQGTSVTVSS,DIQMTQTTSSLSASLGDRVTISCGTSEDIINYLNWYQQKPDGTVKLLIYHTSRLQSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGYTLPYTFGGGTKLEIK
17,humanized,Benralizumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVIHWVRQRPGQGLAWMGYINPYNDGTKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYYGLLGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGTSEDIINYLNWYQQKPGKAPKLLIYHTSRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYTLPYTFGQGTKVEIK
18,mouse,Bevacizumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVRQAPGKGLKWMGWINTYTGEPTYAADFKRRFAFSLETSASTAYLQINNLKNEDMATYFCARYPHYYGSSHWYFDVWGAGTTVTVSS,DIQMTQTTSSLSASLGDRVTISCSASQDISNYLNWYQQKPDGTVKLLIYFTSSLHSGVPSRFSGSGSGTDYFLTISNLEPEDIATYYCQQYSTVPWTFGGGTKLEIK
19,humanized,Bevacizumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK
20,mouse,Blosozumab,EVQLQQSGAELVRPGASVKLSCTASGFNIKDTFQHWVKQRPEQGLEWIGWSDPEIGDTEYASKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCTTGDTTYKFDFWGQGTTLTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVHTAVAWYQQKPGQSPKLLIYWASTRWTGVPDRFTGSGSGTDFTLTISNLQSEDLADYFCQQYSDYPWTFGGGTKLEIK
21,humanized,Blosozumab,QVQLVQSGAEVKKPGASVKVSCKVSGFPIKDTFQHWVRQAPGKGLEWMGWSDPEIGDTEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGDTTYKFDFWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYWASTRWTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSDYPWTFGGGTKVEIK
22,mouse,Bococizumab,QVQLKQPGAELVKPGASVKMSCKASGYTFTSYYMHWVKQRPGQGLDWIGEISPFGGRTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARERPLYASDLWGQGTSVTVSS,DIVMTQSHKSMSTSVGDRVSITCRASQGISSALAWYQQKPGQSPKLLIYSASYRYTGVPGRFTGSGSGTDFTFTISSVQAEDLAVYYCQQRYSLWRTFGGGTKLEIK
23,humanized,Bococizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK
24,mouse,Brontictuzumab,QVQLKQSGAELMKPGASVKLSCKATGYTFTGYWIEWVKQRPGHGLEWIGQILPGTGRTNYNEKFKGKATFTADTSSTPAYMPLSSLTTEDSAIYYCARFDGNYGYYAMDYWGQGTSVTVSS,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQQKPDQLFTGLIGGTNNRAPGVPARFSGSLIGGKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL
25,humanized,Brontictuzumab,QVQLVQSGAEVKKPGASVKISCKVSGYTLRGYWIEWVRQAPGKGLEWIGQILPGTGRTNYNEKFKGRVTMTADTSTDTAYMELSSLRSEDTAVYYCARFDGNYGYYAMDYWGQGTTVTVSS,QAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWFQQKPGQAPRTLIGGTNNRAPGVPARFSGSLLGGKAALTLSGAQPEDEAEYYCALWYSNHWVFGGGTKLTVL
26,mouse,Cabiralizumab,QVQLQQSGPELVKPGASVKIPCKASGYTFTDNYMIWVKQSHGKSLEWIGDINPYNGGTTFNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARESPYFSNLYVMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDNYMNWYQQKPGQPPKLLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCHLSNEDLSTFGGGTKLEIK
27,humanized,Cabiralizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDNYMIWVRQAPGQGLEWMGDINPYNGGTTFNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARESPYFSNLYVMDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCKASQSVDYDGDNYMNWYQQKPGQAPRLLIYAASNLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHLSNEDLSTFGGGTKVEIK
28,mouse,Camrelizumab,EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYMMSWVRQTPEKRLEWVATISGGGANTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTALYYCARQLYYFDYWGQGTTLTVSS,DIQMTQSPASQSASLGESVTITCLASQTIGTWLTWYQQKPGKSPQLLIYTATSLADGVPSRFSGSGSGTKFSFKISSLQAEDFVSYYCQQVYSIPWTFGGGTKLEIK
29,humanized,Camrelizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYMMSWVRQAPGKGLEWVATISGGGANTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLYYFDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCLASQTIGTWLTWYQQKPGKAPKLLIYTATSLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQVYSIPWTFGGGTKVEIK
30,mouse,Cantuzumab,QIQLVQSGPELKKPGETVKISCKASDYTFTYYGMNWVKQAPGKGLKWMGWIDTTTGEPTYAQKFQGRFAFSLETSASTAYLQIKNLKNEDTATYFCARRGPYNWYFDVWGAGTTVTVSS,DIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLVSGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGGGTKLELK
31,humanized,Cantuzumab,QVQLVQSGAEVKKPGETVKISCKASDYTFTYYGMNWVKQAPGQGLKWMGWIDTTTGEPTYAQKFQGRIAFSLETSASTAYLQIKSLKSEDTATYFCARRGPYNWYFDVWGQGTTVTVSS,DIVMTQSPLSVPVTPGEPVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLVSGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGPGTKLELK
32,mouse,Cergutuzumab,QIQLVQSGPELKKPGETVKISCKASGYTFTEFGMNWVKQAPGKGLKWMGWINTKTGEATYVEEFKGRFAFSMETSASTAYLQINNLKNEDMATYFCARWDFAYYVEAMDYWGQGTSVTVSS,DIVMTQSQQFVSTSVGDRVSVTCKASAAVGTYVAWDQQKPGQAPKALMYSASYRKRGVPDRFTGSGSGTDFTLTISNGQSEDLAEYFCHQYYTYPLFTFGSGTKLEIK
33,humanized,Cergutuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTEFGMNWVRQAPGQGLEWMGWINTKTGEATYVEEFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYCARWDFAYYVEAMDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCKASAAVGTYVAWYQQKPGKAPKLLIYSASYRKRGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCHQYYTYPLFTFGQGTKLEIK
34,mouse,Certolizumab,EVQRVESGPELKKPGETVKISCKASGYVFTDYGMNWVKQAPGKGLKWMGWINTYIGEPIYADSVKGRFAFSLETSASTAYLQINNLKNEDTATYFCARGYRSYAMDYWGQGTSVTVSS,DIVMTQSQTSMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKALIYSASFLYSGVPYRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNIYPLTFGAGTKLELK
35,humanized,Certolizumab,EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIK
36,mouse,Citatuzumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKALKWMGWINTYTGESTYADSFKGRFAFSLEPSASAAYLQINNLNNEDTATCFCARFAIKGDYWGQGTTLTVSS,DIVMTQVASSNPVTLGTSASISCRSTKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLEIPRTFGGGTKLELK
37,humanized,Citatuzumab,EVQLVQSGPGLVQPGGSVRISCAASGYTFTNYGMNWVKQAPGKGLEWMGWINTYTGESTYADSFKGRFTFSLDTSASAAYLQINSLRAEDTAVYYCARFAIKGDYWGQGTLLTVSS,DIQMTQSPSSLSASVGDRVTITCRSTKSLLHSNGITYLYWYQQKPGKAPKLLIYQMSNLASGVPSRFSSSGSGTDFTLTISSLQPEDFATYYCAQNLEIPRTFGQGTKVELK
38,mouse,Clivatuzumab,EVQLQQSGPELVKPGASVKMSCKASGYTFPSYVLHWVKQKPGQGLEWIGYINPYNDGTQYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARGFGGSYGFAYWGQGTLVTVSA,QIVLTQSPSIMSASPGEKVTMTCSASSSVSSSYLYWYQQKPGSSPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAASYFCHQWNRYPYTFGGGTKLEIK
39,humanized,Clivatuzumab,QVQLQQSGAEVKKPGASVKVSCEASGYTFPSYVLHWVKQAPGQGLEWIGYINPYNDGTQYNEKFKGKATLTRDTSINTAYMELSRLRSDDTAVYYCARGFGGSYGFAYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTMTCSASSSVSSSYLYWYQQKPGKAPKLWIYSTSNLASGVPARFSGSGSGTDFTLTISSLQPEDSASYFCHQWNRYPYTFGGGTRLEIK
40,mouse,Codrituzumab,QVQLQQSGAELVRPGASVTLSCKASGYTFTDYEMHWVKQTPVHGLEWIGALDPKTGDTAYSQKFKGKAILTADKSSSTAYMELRSLTSEDSAVYYCTRFYSYTYWGQGTTLTVSS,DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNRNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQNTHVPPTFGGGTKLEIK
41,humanized,Codrituzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPGQGLEWMGALDPKTGDTAYSQKFKGRVTLTADKSTSTAYMELSSLTSEDTAVYYCTRFYSYTYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLVHSNRNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQNTHVPPTFGQGTKLEIK
42,mouse,Cofetuzumab,QVQLKQSGPEVVRPGVSVKISCKGSGYTFTDYAVHWVKQSHAKSLEWIGVISTYNDYTYNNQDFKGKATNTVDNSSSTDYMELARLTSEDSAINYCARGNSYFYALDYWGQGTSVTVSS,EIVLTHSPASLPVSLGLRATISCRASESVDSYGKSFMHWYQQKPGQPPKLLIYRASNLESGVPARFSGSGSRTDFTLTINRVEADDVATYYCQQSNEDPWTFGGGTKLEIK
43,humanized,Cofetuzumab,QVQLVQSGPEVKKPGASVKVSCKASGYTFTDYAVHWVRQAPGKRLEWIGVISTYNDYTYNNQDFKGRVTMTRDTSASTAYMELSRLRSEDTAVYYCARGNSYFYALDYWGQGTSVTVSS,EIVLTQSPATLSLSPGERATLSCRASESVDSYGKSFMHWYQQKPGQAPRLLIYRASNLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSNEDPWTFGGGTKLEIK
44,mouse,Concizumab,EVQLVESGGGLVKPGGSLKLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARLGGYDEGDAMDSWGQGTSVTVSS,DVVMTQTPLTLSVTIGQPASISCKSSQSLLESDGKTYLNWLLQRPGESPKLLIYLVSILDSGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCLQATHFPQTFGGGTKLEIK
45,humanized,Concizumab,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGYDEGDAMDSWGQGTTVTVSS,DIVMTQTPLSLSVTPGQPASISCKSSQSLLESDGKTYLNWYLQKPGQSPQLLIYLVSILDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQATHFPQTFGGGTKVEIK
46,mouse,Crenezumab,EVELVESGGGLVQPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLELVASINSNGGSTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCASGDYWGQGTTLTVSS,DIVMTQSPLSLPVSLGDQASISCRSSQSLVYSNGDTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPWTFGGGTKLEIK
47,humanized,Crenezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLVYSNGDTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK
48,mouse,Crizanlizumab,QVQLQQSGPELVKPGALVKISCKASGYTFTSYDINWVKQRPGQGLEWIGWIYPGDGSIKYNEKFKGKATLTADKSSSTAYMQLSSLTSENSAVYFCARRGEYGNYEGAMDYWGQGTSVTVSS,DIVMTQSPASLAVSLGQRATISCKASQSVDYDGHSYMNWYQQKPGQPPKLLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSDENPLTFGGGTKLEIK
49,humanized,Crizanlizumab,QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQAPGKGLEWMGWIYPGDGSIKYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGNYEGAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGHSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSDENPLTFGGGTKVEIK
50,mouse,Dacetuzumab,EVQGVESGPDLVKPGASVKISCKASGYSFTGYYIHWVKQSHGKSLEWIGRVIPNAGGTSYNQKFKGKAILTVDKSSSTAYMELRSLTSEDSAVYYCAREGIYWWGQGTTLTVSS,DIVMTQTPLSLSVSLGDQVSISCRSSQSLVHSNGNTFLHWYLQKPGQSPKLLIYTVSNRFSGVPDSFSGSGSGTDFTLKISRVETEDLGVYFCSQTTHVPWTFGGGTKLEIK
51,humanized,Dacetuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGYYIHWVRQAPGKGLEWVARVIPNAGGTSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREGIYWWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGNTFLHWYQQKPGKAPKLLIYTVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCSQTTHVPWTFGQGTKVEIK
52,mouse,Daclizumab,QVQLQQSGAELAKPGASVKMSCKASGYTFTSYRMHWVKQRPGQGLEWIGYINPSTGYTEYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGGGVFDYWGQGTTLTVSS,QIVLTQSPAIMSASPGEKVTMTCSASSSISYMHWYQQKPGTSPKRWIYTTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSTYPLTFGAGTKLEVK
53,humanized,Daclizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVK
54,mouse,Dalotuzumab,QVQLQQSGPGLVKPSQSLSLTCSVTGYSITGGYLWNWIRQFPGNKLEWMGYISYDGTNNYKPSLKDRISITRDTSKNQFFLKLNSVTTEDTATYYCARYGRVFFDYWGQGTTLTVSS,DIVMTQSPLSLPVSLGDQASISCRSSQSIVHSNGNTYLQWYLQKPGQSPKLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPWTFGGGTKLEIK
55,humanized,Dalotuzumab,QVQLQESGPGLVKPSETLSLTCTVSGYSITGGYLWNWIRQPPGKGLEWIGYISYDGTNNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGRVFFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSIVHSNGNTYLQWYLQKPGQSPQLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPWTFGQGTKVEIK
56,mouse,Dapirolizumab,QVQLKESGPGLVQSSQTLSLTCTVSGFSSTNYHVHWVRQPPGKGLEWMGVIWGDGDTSYNSVLKSRLSISNDTSKSQVFLKMNSLQTEDTATYYCARQLTHYYVLAAWGQGASVTVSS,DIQMTQTTSSMSASLGDRVTISCRASEDLYYNLAWYQRKPGRSVKLLIYDTYRLADGVPSRFSGSGSGADYSLTISSLEPEDVASYYCQQYYKFPFTFGAGTKLEIK
57,humanized,Dapirolizumab,EVQLVESGGGLVQPGGSLRLSCAVSGFSSTNYHVHWVRQAPGKGLEWMGVIWGDGDTSYNSVLKSRFTISRDTSKNTVYLQMNSLRAEDTAVYYCARQLTHYYVLAAWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASEDLYYNLAWYQRKPGKAPKLLIYDTYRLADGVPSRFSGSGSGTDYTLTISSLQPEDFASYYCQQYYKFPFTFGQGTKVEIK
58,mouse,Demcizumab,QVQLQQSGPELVKTGASVKISCKASGYSFTAYYIHWVKQSHGKSLEWIGYISSYNGATNYNQKFKGKATFTVDTSSSTAYMELSSLTSEDSAVYYCARDYDYDVGMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATISCRASESVDNYGISFMKWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSKEVPWTFGGGTKLEIK
59,humanized,Demcizumab,QVQLVQSGAEVKKPGASVKISCKASGYSFTAYYIHWVKQAPGQGLEWIGYISSYNGATNYNQKFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYCARDYDYDVGMDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATISCRASESVDNYGISFMKWFQQKPGQPPKLLIYAASNQGSGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSKEVPWTFGGGTKVEIK
60,mouse,Denintuzumab,QVQLQQSGPGILQPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDDDKRYNPALKSRLTISKDTSSNQVFLKIASVDTADTATYYCARMELWSYYFDYWGQGTTLTVSS,EIVLTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDVATYYCFQGSVYPFTFGSGTKLEIK
61,humanized,Denintuzumab,QVQLQESGPGLVKPSQTLSLTCTVSGGSISTSGMGVGWIRQHPGKGLEWIGHIWWDDDKRYNPALKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARMELWSYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCSASSSVSYMHWYQQKPGQAPRLLIYDTSKLASGIPARFSGSGSGTDFTLTISSLEPEDVAVYYCFQGSVYPFTFGQGTKLEIK
62,mouse,Dezamizumab,QVQLQQPGAELVKPGASVKMSCKASGYTFTTYNMHWVKQTPGQGLEWIGYIYPGDGNANYNQQFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGDFDYDGGYYFDSWGQGTTLTVSS,DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVHNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGAPLTFGAGTKLELK
63,humanized,Dezamizumab,QVQLVQSGAEVKKPGSSVKVSCKASGFTFATYNMHWVRQAPGQGLEWMGYIYPGDGNANYNQQFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGDFDYDGGYYFDSWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIHNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGAPLTFGQGTKLEIK
64,mouse,Domagrozumab,EVKLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTSYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCAKQDYAMNYWGQGTSVTVSS,DIVMTQSPKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPWTFGGGTKLEIK
65,humanized,Domagrozumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISSGGSYTSYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQDYAMNYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKVEIK
66,mouse,Duligotuzumab,EVMLVESGGGLVQPGGSLRLSCAASGFTFSGDWIHWVRQTPEKRLEWVAEISAAGGYTDYADSVKGRFTISRDNAKNNLYLQMSSLKSEDTAMYYCARESRVSFEAAMDYWGQGTSVTVSS,DIVMTQSQKFMSTSVGDRVSVTCRASQNIATDVAWYQQKPGQSPKALIYSASFLYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQSEPEPYTFGGGTKLEIK
67,humanized,Duligotuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTLSGDWIHWVRQAPGKGLEWVGEISAAGGYTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVSFEAAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIK
68,mouse,Eculizumab,QVQLQQSGAELMKPGASVKISCKATGYTFSNYWIQWVKQRPGHGLEWIGEILPGSGSTEYTENFKDKATFTADTSSNTAYMQLSSLTSEDSAVYYCARYFFGSSPNWYFDVWGAGTTVTVSS,DIQMTQSPASLSASVGETVTITCGASENIYGALNWYQRKQGKSPQLLIYGATNLADGMSSRFSGSGSGRQYSLKISSLHPDDVATYYCQNVLNTPLTFGAGTKLELK
69,humanized,Eculizumab,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK
70,mouse,Efalizumab,QVQLQQSGAELVRPGASVKLSCKASGYSFTGHWMNWVKQRPGQGLEWIGMIHPSDSETRYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCARGIYFYGTTYFDYWGQGTTLTVSS,DVQITQSPSYLAASPGETITINCRASKTISKYLAWYQEKPGKTNKLLIYSGSTLQSGIPSRFSGSGSGTDFTLTISSLEPEDFAMYYCQQHNEYPLTFGAGTKLELK
71,humanized,Efalizumab,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIK
72,mouse,Elotuzumab,EVQLVESGGGLVQPGGSLKLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCARPDGNYWYFDVWGAGTTVTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVGIAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYPYTFGGGTKLEIK
73,humanized,Elotuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIK
74,mouse,Emactuzumab,QVQLQQSGAELVKPGASVKMSCKASGYTFTSYDISWVKQRPGQGLEWIGVIWTDGGTNYAQKLQGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARDQRLYFDVWGTGTTVTVSS,NIVMIQSPKSMSMSVGERVTLSCRASEDVNTYVSWYQQKPEQSPQLLIYAASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCQQSFSYPTFGGGTKLEIK
75,humanized,Emactuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDISWVRQAPGQGLEWMGVIWTDGGTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDQRLYFDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASEDVNTYVSWYQQKPGKAPKLLIYAASNRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSFSYPTFGQGTKLEIK
76,mouse,Emibetuzumab,QVQLQQSGPELVKPGASVKISCKASGYTFTDYYMHWVKQSHGKSLEWIGRVNPNRRGTTYNQKFEGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARANWLDYWGQGTTLTVSS,ENVLTQSPAIMSASPGEKVTMTCSVSSSVSSIYLHWYQQKSGASPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQVYSGYPLTFGGGTKLEIK
77,humanized,Emibetuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIK
78,mouse,Emicizumab,QVQLQQSGPELVKPGASVKIPCKASGYTFTDNNMDWVKQSPGKSLEWIGDINTRSGGSIYNEEFQDKATLTVDKSSSTAYMELRSLTSEDTAVYHCARRKSYGYYLDEWGEGTTVTVSS,DIQMNQSPSSLSASLGDTITITCKASRNIERQLAWYQQKPGQSPKLLIYQASRKESGVPDRFTGSRYGTDFTLTISNVQSEDLADYFCQQYSDPPLTFGAGTKLELK
79,humanized,Emicizumab,QVQLVQSGSELKKPGASVKVSCKASGYTFTDNNMDWVRQAPGQGLEWMGDINTRSGGSIYNEEFQDRVIMTVDKSTDTAYMELSSLRSEDTATYHCARRKSYGYYLDEWGEGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASRNIERQLAWYQQKPGQAPELLIYQASRKESGVPDRFSGSRYGTDFTLTISSLQPEDIATYYCQQYSDPPLTFGGGTKVEIK
80,mouse,Enavatuzumab,EVQVVESGGGLVQPGGSMKLSCVASGFTFSSYWMSWVRQSPEKGLEWVAEIRLKSDNYATHYAESVKGKFTISRDDSKSRLYLQMNSLRAEDTGVYYCTTYYADAMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRVTISCRASQSVSTSSYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVEEEDTATYYCQHSWEIPYTFGGGTKLEIK
81,humanized,Enavatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAEIRLKSDNYATHYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYADAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKLLIKYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWEIPYTFGGGTKVEIK
82,mouse,Enoblituzumab,EVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSDSSAIYYADTVKGRFTISRDNPKNTLFLQMTSLRSEDTAMYYCGRGRENIYYGSRLDYWGQGTSVTVSS,DIVMTQSQKFMSTSVGDRVSVTCKASQNVDTNVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNNYPFTFGSGTKLEIK
83,humanized,Enoblituzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSDSSAIYYADTVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCGRGRENIYYGSRLDYWGQGTTVTVSS,DIQLTQSPSFLSASVGDRVTITCKASQNVDTNVAWYQQKPGKAPKALIYSASYRYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNNYPFTFGQGTKLEIK
84,mouse,Enokizumab,QVQLQQSGAELMKPGASVKISCKATGYTFSYYWIEWVKQRPGHGLEWIGEILPGSGTTNPNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARADYYGSDYVKFDYWGQGTTLTVSS,DIVMTQSQIFMSTSVGDRVTVTCKASQHVITHVTWYQQKPGQSPKALIYGTSYSYSGVPNRFTGSGSGTDFTLTISNVQSEDLAEYFCQQFYEYPLTFGAGTKLELK
85,humanized,Enokizumab,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSYYWIEWVRQAPGQGLEWMGEILPGSGTTNPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGSDYVKFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQHVITHVTWYQQKPGKAPKLLIYGTSYSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYEYPLTFGGGTKVEIK
86,mouse,Epratuzumab,QVQLQQSGAELVRPGTSVKLSCKASGYTFTSYWLHWVKQRPGQGLEWIGYINPRNDYTEYNQNFKDKATLTVDTSSSTAYMQLSSLTSEDSAFYYCARRDITTFYWGQGTTLTVSS,NIMMTQSPSSLAVSVGERVTMSCKSSQSVLYSANHKNYLAWYQQKPGQSTKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCHQYLSSWTFGGGTKLEIK
87,humanized,Epratuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYWLHWVRQAPGQGLEWIGYINPRNDYTEYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFCARRDITTFYWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYLSSWTFGGGTKLEIK
88,mouse,Etaracizumab,EVQRVESGGGLVKPGGSLKLSCAASGFAFSSYDMSWVRQTPEKRLEWVAKVSSGGGSTYYLDTVQGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHLHGSFASWGQGTLVTVSA,DIVLTQSTATLSVTPGDRVSLSCQASQSISNFLHWYHQKSGESPRLLIRYRSQSISGIPSRFSGSGSGTDFTLTINSVETEDFGVYFCQQSGSWPLTFGGGTKLELK
89,humanized,Etaracizumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVAKVSSGGGSTYYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHLHGSFASWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCQASQSISNFLHWYQQRPGQAPRLLIRYRSQSISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSGSWPLTFGGGTKVEIK
90,mouse,Farletuzumab,EVQLVESGGDLVKPGGSLKLSCAASGFTFSGYGLSWVRQTPDKRLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLYLQMSSLKSEDTAMYYCARHGDDPAWFAYWGQGTPVTVSA,EIVLTQSPALMAASPGEKVTITCSVSSSISSNNLHWYQQKSETSPKPWIYGTSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSYPYMYTFGGGTKLEIK
91,humanized,Farletuzumab,EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS,DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK
92,mouse,Fibatuzumab,QVQLQQPGAELVKPGASVKMSCKASGYTFTGYWMNWVKQRPGQGLEWIGDIYPGSGNTNYDEKFQGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYYEDFDSWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQGIISYLAWLQQKPEGTIKRLIYAASSLQSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCGQYANYPYTFGGGTKLEIK
93,humanized,Fibatuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYWMNWVRQAPGQGLEWMGDIYPGSGNTNYDEKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGYYEDFDSWGQGTTVTVSS,DIQMTQSPSFLSASVGDRVTITCRASQGIISYLAWYQQKPEKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCGQYANYPYTFGQGTKLEIK
94,mouse,Ficlatuzumab,QVQLQQPGTELVKPGTSVKLSCKASGYTFTTYWMHWVKQRPGQGLEWIGEINPTNGHTNYNQKFQGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARNYVGSIFDYWGQGTTLTVSS,NIVMTQSPKSMSMSVGERVTLSCKASENVVSYVSWYQQKTEQSPKLVIYGASNRESGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQSYNYPYTFGGGTKLEIK
95,humanized,Ficlatuzumab,QVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSS,DIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIK
96,mouse,Flotetuzumab,EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMKWVKQSHGKSLEWIGDIIPSNGATFYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARSHLLRASWFAYWGQGTLVTVSA,DFVMTQSPSSLAVSAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPYTFGGGTKLEIK
97,humanized,Flotetuzumab,EVQLVQSGAELKKPGASVKVSCKASGYTFTDYYMKWVRQAPGQGLEWIGDIIPSNGATFYNQKFKGRVTITVDKSTSTAYMELSSLRSEDTAVYYCARSHLLRASWFAYWGQGTLVTVSS,DFVMTQSPDSLAVSLGERVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGQGTKLEIK
98,mouse,Fontolizumab,QVQLKQPGAELVRPGSSVKLSCKASGYTFTSSWINWVKQRPIQGLEWIGRIDPSDGEVHYNQDFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGFLPWFADWGQGTLVTVSA,NIVMTQSPKSMSMSIGERVTLSCKASENVDTYVSWYQQKPEQSPKLLIYGASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQSYNYPFTFGSGTKLEVK
99,humanized,Fontolizumab,QVQLVQSGAELKKPGSSVKVSCKASGYIFTSSWINWVKQAPGQGLEWIGRIDPSDGEVHYNQDFKDKATLTVDKSTNTAYMELSSLRSEDTAVYYCARGFLPWFADWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCKASENVDTYVSWYQQKPGKAPKLLIYGASNRYTGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCGQSYNYPFTFGQGTKVEVK
100,mouse,Fremanezumab,EVKLVESGGGLVQPGGSMKLSCVASGFTFSNYWISWVRQSPEKGLEWVAEIRSESDASATHYAEAVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCLAYFDYGLAIQNYWGQGTLVTVSA,EIVMTQSPKSMSMSVGERDSLICKASKRVTTYVSWYQQKPEQSPKLLIYGASNRYLGVPDRFTGSGSATYFTLTISSVQAEDLADYHCSQSYNYPYTFGAGTKLEIK
101,humanized,Fremanezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWISWVRQAPGKGLEWVAEIRSESDASATHYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYGLAIQNYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCKASKRVTTYVSWYQQKPGQAPRLLIYGASNRYLGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCSQSYNYPYTFGQGTKLEIK
102,mouse,Galcanezumab,QVQLQQSGAELVRPGTSVKMSCKASGYTFTNYWMQWAKQRPGHGLEWIGAIYEGTGKTVYIQKFADKATLTADKSSSTAYMQFSSLTSEDSAIYYCARLSDYVSGFGYWGQGTTLTVSS,DIQMTQTTSSLSASVGDRVTISCRASKDISKYLNWYQQKPDGTVKLLIYYTSGYHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGDALPPTFGGGTKLEIK
103,humanized,Galcanezumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFGNYWMQWVRQAPGQGLEWMGAIYEGTGKTVYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSDYVSGFGYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASKDISKYLNWYQQKPGKAPKLLIYYTSGYHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDALPPTFGGGTKVEIK
104,mouse,Gatipotuzumab,EVQLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRLKSNNYTTHYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTRHYYFDYWGQGTTLTVSS,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGGGTKLEIK
105,humanized,Gatipotuzumab,EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS,DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK
106,mouse,Gemtuzumab,EVQLQQSGPELVKPGASVKISCKASGYTFTDSNIHWVKQSPGKSLEWIGYIYPYNGGTDYNQKFKNKATLTVDNPSSTAYMELRSLTSEDSAFYYCANGNPWLAYWGQGTLVTVSA,DIVLTQSPATLAVSLGQRATISCRASESLDNYGIRFLTWFQQKPGQPPKLLMYAASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDTAMYFCQQTKEVPWSFGGGTKLEVK
107,humanized,Gemtuzumab,EVQLVQSGAEVKKPGSSVKVSCKASGYTITDSNIHWVRQAPGQSLEWIGYIYPYNGGTDYNQKFKNRATLTVDNPTNTAYMELSSLRSEDTAFYYCVNGNPWLAYWGQGTLVTVSS,DIQLTQSPSTLSASVGDRVTITCRASESLDNYGIRFLTWFQQKPGKAPKLLMYAASNQGSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQTKEVPWSFGQGTKVEVK
108,mouse,Gevokizumab,QVTLKESGPGILKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSQLTISKDTSRNQVFLKITSVDTADTATYYCARNRYDPPWFVDWGQGTLVTVSA,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLSWYQQKPDGTVKLLIYYTSKLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCLQGKMLPWTFGGGTKLEIK
109,humanized,Gevokizumab,QVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSS,DIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIK
110,mouse,Ibalizumab,EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVIHWVKQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCAREKDNYATGAWFAYWGQGTLVTVSA,DIVMTQSPSSLAVSVGEKVTMSCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYRTFGGGTKLEIK
111,humanized,Ibalizumab,QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK
112,mouse,Idarucizumab,QVQLQQSGPGLVAPSQSLSITCTVSGFSLTSYIVDWVRQSPGKGLEWLGVIWAGGSTGYNSALRSRLSISKDNSKSQVYLKMNSLQTDDTAMYYCASAAYYSYYNYDGFAYWGQGTLVTVSA,DVVMTQTPLTLSVTIGQPASISCKSSQSLLYTDGKTYLYWLLQRPGQSPKRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCLQSTHFPHTFGGGTKLEIK
113,humanized,Idarucizumab,QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYIVDWIRQPPGKGLEWIGVIWAGGSTGYNSALRSRVSITKDTSKNQFSLKLSSVTAADTAVYYCASAAYYSYYNYDGFAYWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCKSSQSLLYTDGKTYLYWFLQRPGQSPRRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQSTHFPHTFGGGTKVEIK
114,mouse,Ifabotuzumab,QVQLQQPGAELVKPGASVKMSCKASGYTFTGYWMNWVKQRPGQGLEWIGDIYPGSGNTNYDEKFQGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYYEDFDSWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQGIISYLAWLQQKPEGTIKRLIYAASSLQSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCGQYANYPYTFGGGTKLEIK
115,humanized,Ifabotuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYWMNWVRQAPGQGLEWMGDIYPGSGNTNYDEKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGYYEDFDSWGQGTTVTVSS,DIQMTQSPSFLSASVGDRVTITCRASQGIISYLAWYQQKPEKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCGQYANYPYTFGQGTKLEIK
116,mouse,Iladatuzumab,QVQLQQPGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGGGDTNYNEIFKGEATFTADTSSNTAYMQLSSLTSEDSAVYYCARRVPIRLDYWGQGTLVTVSA,DIVMTQSPASLAVSLGQRATISCKASQSVDYEGDSFLNWFQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
117,humanized,Iladatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK
118,mouse,Imgatuzumab,QVQLQQSGAELAKPGASVKLSCKASGYTFTDYKIHWVKQRPGQGLEWIGYFNPNSGYSTYAQKFQGKATLTADKSSSTAYMQLSSLTYEDSAVYYCARLSPGGYYVMDAWGQGTSVTVSS,DIKMHQSPPSLYPSLGARVTITCRASQGINNYLNWYQQKPGESPKTLIYNTNNLQTGVPSRFSGSGSGQDYSLTISNLEYEDMGIYYCLQHNSFPTFGGGTKLELK
119,humanized,Imgatuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGFTFTDYKIHWVRQAPGQGLEWMGYFNPNSGYSTYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSPGGYYVMDAWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGINNYLNWYQQKPGKAPKRLIYNTNNLQTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSFPTFGQGTKLEIK
120,mouse,Inebilizumab,EVQLQESGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNVKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARSGFITTVRDFDYWGQGTTLTVSS,DIVLTQSPASQAVSLKQKATISCRASESVDTFGISFMNWFQQKPDQPPKLLIHEASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDAAMYFCQQSKEVPFTFGSGTKLEIK
121,humanized,Inebilizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSWMNWVRQAPGKGLEWVGRIYPGDGDTNYNVKFKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARSGFITTVRDFDYWGQGTLVTVSS,EIVLTQSPDFQSVTPKEKVTITCRASESVDTFGISFMNWFQQKPDQSPKLLIHEASNQGSGVPSRFSGSGSGTDFTLTINSLEAEDAATYYCQQSKEVPFTFGGGTKVEIK
122,mouse,Inotuzumab,EVQLQQSGTVLARPGASVKMSCKASGYRFTNYWIHWVKQRPGQGLEWIGGINPGNNYATYRRKFQGKAKLTAVTSTSTAYMELSSLTNEDSAVYYCTREGYGNYGAWFAYWGQGTLVTVSA,DVVVTQTPLSLSVSFGDQVSISCRSSQSLANSYGNTFLSWYLHKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISTIKPEDLGMYYCLQGTHQPYTFGSGTKLEIK
123,humanized,Inotuzumab,EVQLVQSGAEVKKPGASVKVSCKASGYRFTNYWIHWVRQAPGQGLEWIGGINPGNNYATYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCTREGYGNYGAWFAYWGQGTLVTVSS,DVQVTQSPSSLSASVGDRVTITCRSSQSLANSYGNTFLSWYLHKPGKAPQLLIYGISNRFSGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCLQGTHQPYTFGQGTKVEIK
124,mouse,Itolizumab,EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQTPEKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTTLTVSS,DIKMTQSPSSTYASLGARVTITCKASRDIRSYLTWYQQKPWKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK
125,humanized,Itolizumab,EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQAPGKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASRDIRSYLTWYQQKPGKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK
126,mouse,Ixekizumab,QVQLQQSGPELVKPGASVKISCKASGYSFTDYHIHWVKQSPGKGLEWIGVINPMYGTTDYNQRFKGKATLTVDQSSSTAYMQLNSLTSEDSAVYYCARYDYFTGTGVYWGQGTLVTVSA,DIVLTQSTLSLPVSLGDQASISCRSSRSLVHSRGNTYLHWYLQKPGQSPKLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHLPFTFGSGTKLEIK
127,humanized,Ixekizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSS,DIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIK
128,mouse,Labetuzumab,EVQLQESGGGLVQPGGSLKLSCAASGFDFSTYWMSWVRQAPGKGLEWIGEIHPDSSTINYAPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCATLYFGFPWFAYWGQGTPVTVSA,DIVMTQSPKFMSTSVGDRVSITCKASQDVGTSVAWYQQKPGQSPKLLIYWTSTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSLYRSFGGGTKLEIK
129,humanized,Labetuzumab,EVQLVESGGGVVQPGRSLRLSCSASGFDFTTYWMSWVRQAPGKGLEWIGEIHPDSSTINYAPSLKDRFTISRDNAKNTLFLQMDSLRPEDTGVYFCASLYFGFPWFAYWGQGTPVTVSS,DIQLTQSPSSLSASVGDRVTITCKASQDVGTSVAWYQQKPGKAPKLLIYWTSTRHTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYSLYRSFGQGTKVEIK
130,mouse,Lacnotuzumab,EVQLQESGPGLVKPSQSLSLTCTVTDYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARFDYAHAMDYWGQGTSVTVSS,DILLTQSPAILSVSPGEKVSFSCQASQSIGTSIHWYQQKTDGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDAADYYCQQINSWPTTFGGGTKLEIK
131,humanized,Lacnotuzumab,QVQLQESGPGLVKPSQTLSLTCTVSDYSITSDYAWNWIRQFPGKGLEWMGYISYSGSTSYNPSLKSRITISRDTSKNQFSLQLNSVTAADTAVYYCASFDYAHAMDYWGQGTTVTVSS,DIVLTQSPAFLSVTPGEKVTFTCQASQSIGTSIHWYQQKTDQAPKLLIKYASESISGIPSRFSGSGSGTDFTLTISSVEAEDAADYYCQQINSWPTTFGGGTKLEIK
132,mouse,Ladiratuzumab,EVQLQQSGAELVKPGASVKLSCTASGLNIEDYYMHWVKQRPEQGLEWIGWIDPENGDTEYGPKFQGKATMTADTSSNTAYLQLSSLTSEDTAVYYCNVHNAHYGTWFAYWGQGTLVTVSA,DVLMTQTPPSLPVSLGDQASISCRSSQSLLHSSGNTYLEWYLQKPGQSPKPLIYKISTRFSGVPDRFSGSGSGTDFTLKISSVEAEDLGVYYCFQGSHVPYTFGGGTKLEIK
133,humanized,Ladiratuzumab,QVQLVQSGAEVKKPGASVKVSCKASGLTIEDYYMHWVRQAPGQGLEWMGWIDPENGDTEYGPKFQGRVTMTRDTSINTAYMELSRLRSDDTAVYYCAVHNAHYGTWFAYWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLLHSSGNTYLEWYQQRPGQSPRPLIYKISTRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPYTFGGGTKVEIK
134,mouse,Lambrolizumab,QVQLQQSGVELVKPGVSVKLSCKASGYTFTNYYMYWVKQRPGQDLEWIGGINPSNGGTNFNEKFKNKATPTVDSSSSTAYMQLKSLQFEDSAVYFCARRDYRFDMGFDYWGQGTTLTVSS,DIVLTQSPASLAVSLGQRATISCRASKGVSTSGYSYLHWYQQKPGQPPKLLIYLASYLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRDLPLTFGGGTKLEIK
135,humanized,Lambrolizumab,QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK
136,mouse,Lampalizumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGETTYADDFKGRFVFSLDTSVSTAYLQINNLKNEDMATYSCEREGGVNNWGQGTMVTVSA,ETTVTQSPASLSMAIGEKVTIRCITSTDIDDDMNWYQQKPGEPPKLLISGGNTLRPGVPSRFSSSGYGTDFVFTIENMLSEDVADYYCLQSDSLPYTFGGGTKLEIK
137,humanized,Lampalizumab,EVQLVQSGPELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGETTYADDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCEREGGVNNWGQGTLVTVSS,DIQVTQSPSSLSASVGDRVTITCITSTDIDDDMNWYQQKPGKVPKLLISGGNTLRPGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLQSDSLPYTFGQGTKVEIK
138,mouse,Landogrozumab,EVQLVESGGGLVQPGRSLKLSCAASGFTFSRYPMSWVRQAPKKGLEWVAAITSSGGSTYYSDTVKGRFTISRDNAKNTLYLQMNSLRSEDTATYYCARLPDYWGQGTLVTVSS,ENVLTQSPAIMSASPGEKVTMTCRASSSVSSSYLHWYQQKSGASPKLWIYSTSNLVAGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQHHSGYHFTFGSGTKLEIK
139,humanized,Landogrozumab,EVQLVESGGGLVQPGGSLRLSCAASGLTFSRYPMSWVRQAPGKGLVWVSAITSSGGSTYYSDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARLPDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASSSVSSSYLHWYQQKPGQAPRLLIYSTSNLVAGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHHSGYHFTFGGGTKVEIK
140,mouse,Lebrikizumab,QVQLRESGPGLVAPSQSLSITCTVSGFSLTAYSVNWVRQPPGKGLEWLGMIWGDGKIVYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARDGYYPYAMDNWGQGSSVTVSS,DIVMTQSPASLAVSLGQRATISCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPRTFGGGTKLEIK
141,humanized,Lebrikizumab,QVTLRESGPALVKPTQTLTLTCTVSGFSLSAYSVNWIRQPPGKALEWLAMIWGDGKIVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYYPYAMDNWGQGSLVTVSS,DIVMTQSPDSLSVSLGERATINCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQNNEDPRTFGGGTKVEIK
142,mouse,Lifastuzumab,EVQLVESGGGVVQPGKSLKLSCAASGFSFSDFAMSWVRQSPKMGLEWVATIGRVAFHTYYPDSMKGRFIISRDNAKNTLYLQMDSLRSEETATYYCARHRGFDVGHFDFWGPGTMVTVSS,DIQMTQTPLSLPVSLGDQAAISCRSSETLVHSSGNTYLEWYLQKPGQSPKLLIYRVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSFNPLTFGAGTKLELK
143,humanized,Lifastuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFSFSDFAMSWVRQAPGKGLEWVATIGRVAFHTYYPDSMKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHRGFDVGHFDFWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSETLVHSSGNTYLEWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSFNPLTFGQGTKVEIK
144,mouse,Ligelizumab,QVQLQQPGAELMRPGSSVKLSCKASGYTFTWYWLEWVKQRPIHGLEWIGEIDPGTFTTNYNEKFKAKATFTVDKSSSTAYMQLSSLTSEDSAVYYCARFSHFSGSNYDYFDYWGQGTTLTVSS,DILLTQSPAILSVSPGERVSFSCRASQSIGTNIHWYQQKTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQSWSWPTTFGGGTKLEIK
145,humanized,Ligelizumab,QVQLVQSGAEVMKPGSSVKVSCKASGYTFSWYWLEWVRQAPGHGLEWMGEIDPGTFTTNYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGSNYDYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIYYASESISGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQSWSWPTTFGGGTKVEIK
146,mouse,Lintuzumab,QVQLQQSGAELVKPGASVKISCKASGYTFTDYNMHWVKQSHGKSLEWIGYIYPYNGGTGYNQKFKSKATLTVDNSSSTAYMELRSLTSEDSAVYYCARGRPAMDYWGQGTSVTVSS,DIVLTQSPASLAVSVGQRATITCRASESVDNYGISFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDTAMYFCQQSKEVPWTFGGGTKLEIK
147,humanized,Lintuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK
148,mouse,Lorvotuzumab,EVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSGSFTIYYADSVKGRFTISRDNPKNTLFLQMTSLRSEDTAMYYCARMRKGYAMDYWGQGTSVTVSS,DVVMTQTPLSLPVSLGDQASISCRSSQIIIHSDGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPHTFGGGTKLEIK
149,humanized,Lorvotuzumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSGSFTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARMRKGYAMDYWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQIIIHSDGNTYLEWFQQRPGQSPRRLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPHTFGQGTKVEIK
150,mouse,Lumretuzumab,QVQLQQSGAELVKPGASVKLSCKTSGFTFSSSYISWLKQKPGQSLEWIAWIYAGTGSPSYNQKLQGKAQLTVDTSSSTAYMQFSSLTTEDSAIYYCARHRDYYSNSLTYWGQGTTLTVSS,DIVMTQSPSSLTVTAGEKVTMSCKSSQSVLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQSDYSYPYTFGGGTKLEIK
151,humanized,Lumretuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFRSSYISWVRQAPGQGLEWMGWIYAGTGSPSYNQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARHRDYYSNSLTYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQSDYSYPYTFGQGTKLEIK
152,mouse,Lutikizumab,EVKLQESGGGLVKPGGSLKLSCAASGFTFSRYDMSWVRQTPEKRLEGVAYISHGGAGTYYPDSVKGRFTISRDNAKNNLYLQMSHLKSEDTAMYYCARGGVTKGYFDVWGTGTPVTVSS,DIQMTQSPASLSASVGETVTITCRASGNIHNYLTWYQQTQGKSPQLLIYNAKTLADGVPSRFSGSGSGTQYSLKINSLQPEDFGIYYCQHFWSIPYTFGGGTKLQIT
153,humanized,Lutikizumab,EVQLVESGGGVVQPGRSLRLSCSASGFIFSRYDMSWVRQAPGKGLEWVAYISHGGAGTYYPDSVKGRFTISRDNSKNTLFLQMDSLRPEDTGVYFCARGGVTKGYFDVWGQGTPVTVSS,DIQMTQSPSSLSASVGDRVTITCRASGNIHNYLTWYQQTPGKAPKLLIYNAKTLADGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQHFWSIPYTFGQGTKLQIT
154,mouse,Matuzumab,QVQLQQSGAELVKPGASVKLSCKASGYTFTSHWMHWVKQRPGQGLEWIGEFNPSNGRTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCASRDYDYDGRYFDYWGAGTTVTVSS,DIVLTQSPAILSASPGEKVTMTCSASSSVTYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSHIFTFGSGTKLEIK
155,humanized,Matuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIK
156,mouse,Mepolizumab,QVQLRESGPGLVAPSQSLSITCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDNSKSQVCLKMNSLQIDDPAMYYCARDPPSSLLRLDYWGQGTPVTVSS,DIVMTQSPSSLSVSAGEKVTMSCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNVHSFPFTFGSGTKLEIK
157,humanized,Mepolizumab,QVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK
158,mouse,Milatuzumab,QLQLVQSGPELKKPGETVKISCKASGYTFTNYGVNWVKQAPGKGLQWMGWINPNTGEPTFDDDFKGRFAFSLETSVSTAYLQLTNLKNEDTATYFCSRSRGKNEAWFAYWGQGTLVTVSA,DIVLTQSPLSLPVSLGDQASISCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIYTVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSSHVPPTFGAGTKLEIK
159,humanized,Milatuzumab,QVQLQQSGSELKKPGASVKVSCKASGYTFTNYGVNWIKQAPGQGLQWMGWINPNTGEPTFDDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFCSRSRGKNEAWFAYWGQGTLVTVSS,DIQLTQSPLSLPVTLGQPASISCRSSQSLVHRNGNTYLHWFQQRPGQSPRLLIYTVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFCSQSSHVPPTFGAGTRLEIK
160,mouse,Mirikizumab,QVQLKQSGPELVKPGASVKVSCKASGYKFTRYVMHWVKQKPGQGLEWIGYINPYNDGTNYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARNWDTGLWGQGTLVTVSA,DIQMTQSPSSLSASLGGRVTITCKASDHILKFLTWYQQKPGNAPRLLISGATSLETGVPSRFSGSGSGKDYTLSITSLQTEDVATYYCQMYWSTPFTFGSGTKLEIK
161,humanized,Mirikizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYKFTRYVMHWVRQAPGQGLEWMGYINPYNDGTNYNEKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNWDTGLWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCKASDHILKFLTWYQQKPGKAPKLLIYGATSLETGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQMYWSTPFTFGGGTKVEIK
162,mouse,Mogamulizumab,EVQLVESGGDLVKPGGSLKLSCAASGFTFSNYGMSWVRQTPDKRLEWVATISSASTYSYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCGRHSDGNFAFGYWGQGTTLTVSS,DVLMTQTPLSLPVSLGDQASISCRSSRNIVHINGDTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSLLPWTFGGGTKLEIK
163,humanized,Mogamulizumab,EVQLVESGGDLVQPGRSLRLSCAASGFIFSNYGMSWVRQAPGKGLEWVATISSASTYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGNFAFGYWGQGTLVTVSS,DVLMTQSPLSLPVTPGEPASISCRSSRNIVHINGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTKVEIK
164,mouse,Monalizumab,QVQLQQSGAELVRPGSSVKLSCKASGYTFTSYWMNWVKQRPIQGLEWIGRIDPYDSETHYAQKLQGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGGYDFDVGTLYWFFDVWGTGTTVTVSS,DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLIYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGTPRTFGGGTKLEIK
165,humanized,Monalizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMNWVRQAPGQGLEWMGRIDPYDSETHYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGYDFDVGTLYWFFDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGTPRTFGGGTKVEIK
166,mouse,Mosunetuzumab,QVQLQQSGAELVRPGASVKLSCKASGYTFTNYYIHWVKQRPGQGLEWIAWIYPGDGNTKYNEKFKGKATLTAEKSSSTAYMQLSSLTSEDSAVYFCARDSYSNYYFDYWGQGTTLTVSS,DIVMTQSPSSLAVSAGEKVTMSCKSSQSLLNSRTRKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCTQSFILRTFGGGTKLEIK
167,humanized,Mosunetuzumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYIHWVRQAPGQGLEWIGWIYPGDGNTKYNEKFKGRATLTADTSTSTAYLELSSLRSEDTAVYYCARDSYSNYYFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSRTRKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCTQSFILRTFGQGTKVEIK
168,mouse,Motavizumab,QVTLRVSGPGILQPSQTLSLTCSFSGFSLSTAGMSVGWIRQPSGKGLEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVFLKIANGDTADTATYYCARDMIFNFYFDVWGTGTTVTVSS,DIVMTQSPAIMSASPGEKVTITCSASSRVGYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCFQGSGYPFTFGSGTKLEIK
169,humanized,Motavizumab,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIK
170,mouse,Natalizumab,QVQLQQSGAELVKPGASVKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIDPANGYTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAIYYCAREGYYGNYGVYAMDYWGQGTSVTVSS,DIQMTQSPSSLSASLGGKVTITCKTSQDINKYMAWYQHTPGKGPRLLIHYTSALQPGIPSRFSGSGSGRDYSFSISNLEPEDIATYYCLQYDNLWTFGGGTKLEIK
171,humanized,Natalizumab,QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIK
172,mouse,Nemolizumab,EVQLQQSGPELVKPGASVKMSCKASGYTFTGYIMNWVKQKPGQGLEWIGLINPYNGGTDYNPQFQDKATLTSDKSSSTAYMELSSLTSEDSAVYDCARDGYDDGPYTLETWGQGTTLTVSS,DIQMTKSPASLSASVGETVTITCQASEDIYSFVAWYQQKQGKSPQLLVYNAQTEAQGVPSRFSGSGSGTQFSLKISSLQPEDFGSYYCQHHYDSPLTFGAGTKLELK
173,humanized,Nemolizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYIMNWVRQAPGQGLEWMGLINPYNGGTDYNPQFQDRVTITADKSTSTAYMELSSLRSEDTAVYYCARDGYDDGPYTLETWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASEDIYSFVAWYQQKPGKAPKLLIYNAQTEAQGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYDSPLTFGGGTKVEIK
174,mouse,Nimotuzumab,QVQLQQSGAELVKPGASVKLSCKASGYTFTNYYIYWVKQRPGQGLEWIGGINPTSGGSNFNEKFKTKATLTVDKSSSTAYMQLSSLTSEDSAFYYCTRQGLWFDSDGRGFDFWGQGTTLTVSS,DVLMTQTPLSLPVSLGDQASISCRSSQNIVHSNGNTYLDWYLQTPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQYSHVPWTFGGGTKLQIT
175,humanized,Nimotuzumab,QVQLQQSGAEVKKPGSSVKVSCKASGYTFTNYYIYWVRQAPGQGLEWIGGINPTSGGSNFNEKFKTRVTITADESSTTAYMELSSLRSEDTAFYFCTRQGLWFDSDGRGFDFWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQNIVHSNGNTYLDWYQQTPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFQYSHVPWTFGQGTKLQIT
176,mouse,Obinutuzumab,QVQLQQSGPELVKPGASVKISCKASGYAFSYSWINWVKQRPGQGLEWIGRIFPGDGDTDYNGKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARNVFDGYWLVYWGQGTLVTVSA,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK
177,humanized,Obinutuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS,DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK
178,mouse,Ocaratuzumab,QVQLQQSGAELVRPGASVKMSCKASGRTFTSYNMHWVKQTPRQGLEWIGAIYPLTGDTSYNQKSKLKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARSTYVGGDWQFDVWGTGTTVTVSS,QIVLSQSPAILSASPGEKATMTCRASSSVPYIHWYQQKPGSSPKPWIYATSALASGIPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWLSNPPTFGGGTKLEIK
179,humanized,Ocaratuzumab,EVQLVQSGAEVKKPGESLKISCKGSGRTFTSYNMHWVRQMPGKGLEWMGAIYPLTGDTSYNQKSKLQVTISADKSISTAYLQWSSLKASDTAMYYCARSTYVGGDWQFDVWGKGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASSSVPYIHWYQQKPGQAPRLLIYATSALASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQWLSNPPTFGQGTKLEIK
180,mouse,Ocrelizumab,QVQLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSS,QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSFNPPTFGGGTKLEIK
181,humanized,Ocrelizumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYNMHWVRQAPGKGLEWVGAIYPGNGDTSYNQKFKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSNSYWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASSSVSYMHWYQQKPGKAPKPLIYAPSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSFNPPTFGQGTKVEIK
182,mouse,Olendalizumab,QVQLQQSGPELVKPGASVKISCKASGYTFTDYSMDWVKQSHGKSLEWIGAIHLNTGYTNYNQKFKGKATLNVDKSSSTAYMELRSLTSEDSAVYYCARGFYDGYSPMDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFMHWYQQKPGQPPKLLIYRASNLESGVPARFSGSGSRTDFTLTISPVEADDVATYYCQQSNEDPYTFGGGTKLEIK
183,humanized,Olendalizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYSMDWVRQAPGQGLEWMGAIHLNTGYTNYNQKFKGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGFYDGYSPMDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASESVDSYGNSFMHWYQQKPGKAPKLLIYRASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPYTFGGGTKVEIK
184,mouse,Omalizumab,EVQLQESGPGLVKPSQSLSLTCSVTGYSITSGYSWNWIRQFPGNKLEWMGSITYDGSTNYNPSVKGRISITRDTSKNQFFLKLNSVTTEDTATYYCARGSHYFGHWHFAVWGTGTTVTVSS,DIVLTQSPASLAVSLGQRATISCRASQSVDYDGDSYMNWYQQKPGQAPKLLIYAASYLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSHEDPYTFGGGTKLEIK
185,humanized,Omalizumab,EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIK
186,mouse,Onartuzumab,QVQLQQSGPELVRPGASVKMSCTASGYTFTSYWLHWVKQRPGQGLEWIGMIDPSNSDTRFNPNFKDKATLNVDKSSNTAYMQLSSLTSEDSAVYYCATYRSYVTPLDYWGQGTTLTVSS,DIVMSQSPSSLAVSVGEKVTMSCKSSQSLLYTSSQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQQYYAYPWTFGGGTKLEIK
187,humanized,Onartuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYWLHWVRQAPGKGLEWVGMIDPSNSDTRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSYVTPLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYAYPWTFGQGTKVEIK
188,mouse,Oportuzumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKALKWMGWINTYTGESTYADSFKGRFAFSLEPSASAAYLQINNLNNEDTATCFCARFAIKGDYWGQGTTLTVSS,DIVMTQVASSNPVTLGTSASISCRSTKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLEIPRTFGGGTKLELK
189,humanized,Oportuzumab,EVQLVQSGPGLVQPGGSVRISCAASGYTFTNYGMNWVKQAPGKGLEWMGWINTYTGESTYADSFKGRFTFSLDTSASAAYLQINSLRAEDTAVYYCARFAIKGDYWGQGTLLTVSS,DIQMTQSPSSLSASVGDRVTITCRSTKSLLHSNGITYLYWYQQKPGKAPKLLIYQMSNLASGVPSRFSSSGSGTDFTLTISSLQPEDFATYYCAQNLEIPRTFGQGTKVELK
190,mouse,Otlertuzumab,EVQLQQSGPELEKPGASVKISCKASGYSFTGYNMNWVKQSNGKSLEWIGNIDPYYGGTTYNRKFKGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCARSVGPFDSWGQGTTLTVSS,DIQMTQSPASLSASVGETVTITCRASENVYSYLAWYQQKQGKSPQLLVYFAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHSDNPWTFGGGTKLEIK
191,humanized,Otlertuzumab,EVQLVQSGAEVKKPGESLKISCKGSGYSFTGYNMNWVRQMPGKGLEWMGNIDPYYGGTTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARSVGPFDSWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASENVYSYLAWYQQKPGQAPRLLIYFAKTLAEGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHHSDNPWTFGQGTKVEIK
192,mouse,Ozanezumab,QVQLQQSGTELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNINPSNGGTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCELMQGYWGQGTTLTVSS,DIVITQDELSNPVTSGESVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGSGSGTDFTLEISRVKAEDVGVYYCQQLVEYPLTFGAGTKLELK
193,humanized,Ozanezumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSS,DIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIK
194,mouse,Palivizumab,QVTLRVSGPGLLKPSQTLSLTCSFSGFSLSTSGMSVGWIRQPSGKGLEWLADIWWDDKKDYNPSLKSQLTISKDTSRNQVFLKITSVDTADTATYYCARSMITNWYFDVWGAGTTVTVSS,DIVLTQTPAIMSASPGEKVTMTCKCQLSVGYMHWYQQKSSTSPKLWIYDTSKLASGVPGRFSGSGSGNSYSLTISSMEAEDVATYYCFQGSGYPFTFGSGTKLEIK
195,humanized,Palivizumab,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK
196,mouse,Parsatuzumab,EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINLDNSGTHYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCAREGVYHDYDDYAMDYWGQGTSVTGSS,DVVMTQTPLSLPVSLGDQASISCRTSQSLVHINAITYLHWYLQKPGQSPKLLIYRVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCGQSTHVPLTFGAGTKLELK
197,humanized,Parsatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFIDYYMNWVRQAPGKGLEWVGDINLDNSGTHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDYDDYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSLVHINAITYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCGQSTHVPLTFGQGTKVEIK
198,mouse,Pateclizumab,EVQLKESGPELVKPGASVKMSCKASGYTFTSYVIHWVKQKPGQGLEWIGYNNPYNAGTNYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCSRPTMLPWFAYWGQGTLVTVSA,DIVITQSHKFMSTSVGDRVSITCRASQAVSSAVAWYQQKPGQSPKLLIYSASHRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQESYSTPWTFGGGTKLEIK
199,humanized,Pateclizumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYVIHWVRQAPGKGLEWVGYNNPYNAGTNYNEKFKGRFTISSDKSKNTAYLQMNSLRAEDTAVYYCSRPTMLPWFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQAVSSAVAWYQQKPGKAPKLLIYSASHRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQESYSTPWTFGQGTKVEIK
200,mouse,Pembrolizumab,QVQLQQSGVELVKPGVSVKLSCKASGYTFTNYYMYWVKQRPGQDLEWIGGINPSNGGTNFNEKFKNKATPTVDSSSSTAYMQLKSLQFEDSAVYFCARRDYRFDMGFDYWGQGTTLTVSS,DIVLTQSPASLAVSLGQRATISCRASKGVSTSGYSYLHWYQQKPGQPPKLLIYLASYLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRDLPLTFGGGTKLEIK
201,humanized,Pembrolizumab,QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK
202,mouse,Perakizumab,EVQLVESGGGLVKPGGSLKLSCAASGFTFSDYTMLWVRQTPEKRLEWVAIIKSGGSYSYYPDSVKGRFTISRDNAKNNLYLQMSSLKSEDTAMYYCARDGDYGSSYGAMDYWGQGTSVTVSS,DIKMTQSPSSMYASLGERVTITCRASQDINSYLSWFQQKPGKSPKTLIVRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDRGIYYCLQYDAFPPYTFGGGTKLEIK
203,humanized,Perakizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYTMLWVRQAPGKGLEWVAIIKSGGSYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDGDYGSSYGAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDINSYLSWFQQKPGKAPKSLIVRANRLVDGVPSRFSGSGSGQDYSLTISSLQPEDFATYYCLQYDAFPPYTFGQGTKLEIK
204,mouse,Pertuzumab,EVQLQESGPELVKPGASVKIPCKASGYTFTDYTMDWVKQSHGKSLEWIGDVNPNSGGSIYNQRFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARNLGPSFYFDYWGQGTTLTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVSIGVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQYYIYPYTFGGGTKLEIK
205,humanized,Pertuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIK
206,mouse,Pidilizumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLQWMGWINTDSGESTYAEEFKGRFVFSLETSVSTAYLQINNLKNEDTATYFCVRVGYDALDYWGQGTSVTVSS,QIVLTQSPAIMSASPGEMVTITCSARSSVSYMHWFQQKPGTSPKLWIYRTSNLASGVPARFSGSGSGTSYCLTISRMEAEDAATYYCQQRSSFPLTFGAGTKLELK
207,humanized,Pidilizumab,QVQLVQSGSELKKPGASVKISCKASGYTFTNYGMNWVRQAPGQGLQWMGWINTDSGESTYAEEFKGRFVFSLDTSVNTAYLQITSLTAEDTGMYFCVRVGYDALDYWGQGTLVTVSS,EIVLTQSPSSLSASVGDRVTITCSARSSVSYMHWFQQKPGKAPKLWIYRTSNLASGVPSRFSGSGSGTSYCLTINSLQPEDFATYYCQQRSSFPLTFGGGTKLEIK
208,mouse,Pinatuzumab,EVQLQESGPELVKPGASVKISCKASGYEFSRSWMNWVKQRPGKGLEWIGRIYPGDGDTNYSGKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARDGSSWDWYFDVWGTGTTVTVSS,DVLMTQTPLSLPISLGDQASISCRSSQSIVHSVGNTFLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSQFPYTFGGGTKLEIK
209,humanized,Pinatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYEFSRSWMNWVRQAPGKGLEWVGRIYPGDGDTNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSWDWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQSIVHSVGNTFLEWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSQFPYTFGQGTKVEIK
210,mouse,Pogalizumab,ELQLKESGPELVEPGASMKMSCKASGYTFTDSYMSGVRQSHGKSLEWIGDMYPDNGDSSYNQKFREKATLTVDRSSSTAYMQLDSLTSEDSAAHYCVLAPRWYFSVWGAGTTVTVSS,DIQMTQTPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLRSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGHTLPPTFGGGTKLEIK
211,humanized,Pogalizumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDSYMSWVRQAPGQGLEWIGDMYPDNGDSSYNQKFRERVTITRDTSTSTAYLELSSLRSEDTAVYYCVLAPRWYFSVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLRSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGHTLPPTFGQGTKVEIK
212,mouse,Polatuzumab,QVQLQQPGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGGGDTNYNEIFKGEATFTADTSSNTAYMQLSSLTSEDSAVYYCARRVPIRLDYWGQGTLVTVSA,DIVMTQSPASLAVSLGQRATISCKASQSVDYEGDSFLNWFQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
213,humanized,Polatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK
214,mouse,Prasinezumab,EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMSWVRQTPTKGLEWVASISSGGGSTYYPDNVKGRFTISRDNAKNTQYLQMDSLRSEDTATYYCARGGAGIDYWGQGTLVTVSS,DIVMSQSPSSLAVSVREKVTMSCKSIQTLLYSSNQKNYLAWYQQKPGQSPKLLIYWASIRKSGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYPLTFGAGTKLELK
215,humanized,Prasinezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASISSGGGSTYYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYCARGGAGIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKSIQTLLYSSNQKNYLAWFQQKPGKAPKLLIYWASIRKSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQYYSYPLTFGGGTKLEIK
216,mouse,Quilizumab,EVQLVESGGGLVQPGGSLKLSCAASGFTFSDYGIAWVRQAPRKGPEWVAFISDLAYTIYYADTVTGRFTISRENAKNTLYLEMSSLRSEDTAMYYCARDNWDAMDYWGQGTSVTVSS,DVVMTQTPLSLPVSLGDQASISCRSSQSLVHNNANTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCSQNTLVPWTFGGGTKLEIK
217,humanized,Quilizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYGIAWVRQAPGKGLEWVAFISDLAYTIYYADTVTGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDNWDAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQSLVHNNANTYLHWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCSQNTLVPWTFGQGTKVEIK
218,mouse,Ralpancizumab,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYYMHWVKQRPGQGLEWIGEIHPSGGRTNYNEKFKSKATMTVDKSSSTAYMQLSSLTSEDSAVYYCARERPLYASDLWGQGTSVTVSS,DIVMTQSHKSMSTSVGDRVSITCKASQDVHTAVAWYQQKPGQSPKLLIYHASYRYTGVPGRFTGSGSGTDFTFTISSVQAEDLAVYYCQQRYSLWRTFGGGTKLEIK
219,humanized,Ralpancizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEIHPSGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYHASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK
220,mouse,Ranibizumab,QIQLVQSGPELKKPGETVKISCKASGYDFTHYGMNWVRQAPGKGLKWMGWINTYTGEPTYAADFKRRFAFSLETSASTAYLQINNLKNEDMATYFCARYPYYYGTSHWYFDVWGAGTTVTVSS,DIQMTQTTSSLSASLGDRVTISCSASQDISNYLNWYQQKPDGTVKLLIYFTSSLHSGVPSRFSGSGSGTDYFLTISNLEPEDIATYYCQQYSTVPWTFGGGTKLEIK
221,humanized,Ranibizumab,EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK
222,mouse,Ravulizumab,QVQLQQSGAELMKPGASVKISCKATGHTFSNYWIQWVKQRPGHGLEWIGEILPGSGHTEYTENFKDKATFTADTSSNTAYMQLSSLTSEDSAVYYCARYFFGSSPNWYFDVWGAGTTVTVSS,DIQMTQSPASLSASVGETVTITCGASENIYGALNWYQRKQGKSPQLLIYGATNLADGMSSRFSGSGSGRQYSLKISSLHPDDVATYYCQNVLNTPLTFGAGTKLELK
223,humanized,Ravulizumab,QVQLVQSGAEVKKPGASVKVSCKASGHIFSNYWIQWVRQAPGQGLEWMGEILPGSGHTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK
224,mouse,Refanezumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFTGRFVFSLETSVSTAYLQINNLKNEDTATYFCARNPINYYGINYEGYVMDYWGQGTSVTVSS,NIMMTQSPSSLAVSAGEKVTISCKSSHSVLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCHQYLSSLTFGAGTKLELK
225,humanized,Refanezumab,QVQLVQSGSELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARNPINYYGINYEGYVMDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSHSVLYSSNQKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCHQYLSSLTFGQGTKLEIK
226,mouse,Reslizumab,QVQLKESGPGLVQPSQTLSLTCTVSGLSLTSNSVNWIRQPPGKGLEWMGLIWSNGDTDYNSAIKSRLVISRDTSKSQVFLKMNSLQAEDTAMYFCAREYYGYFDYWGQGVMVTVSS,DIVLTQSPSSMYSSLGERVTITCLASEGISSYLAWFQQKPGKSPKTLISGANSLQTGVPSRFSGSGSAQDYSLTISSLDYEDVGIYYCQQSYKFPNTFGGGTKLEVK
227,humanized,Reslizumab,EVQLVESGGGLVQPGGSLRLSCAVSGLSLTSNSVNWIRQAPGKGLEWVGLIWSNGDTDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYYGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCLASEGISSYLAWYQQKPGKAPKLLIYGANSLQTGVPSRFSGSGSATDYTLTISSLQPEDFATYYCQQSYKFPNTFGQGTKVEVK
228,mouse,Risankizumab,QVQLQQSDAELVKPGASVKISCKVSGYTFTDQTIHWMKQRPEQGLEWIGYIYPRDDSPKYNENFKGKATLTADKSSSTAYMQLNSLTSEDYAVYFCAIPDRSGYAWFIYWGQGTLVTVSA,DIVMTQSHKFMSTSVGDRVSITCKASRDVAIAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSRTDFTLTISNVQSEDLADYFCHQYSSYPFTFGSGTKLEIK
229,humanized,Risankizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDQTIHWMRQAPGQGLEWIGYIYPRDDSPKYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYCAIPDRSGYAWFIYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASRDVAIAVAWYQQKPGKVPKLLIYWASTRHTGVPSRFSGSGSRTDFTLTISSLQPEDVADYFCHQYSSYPFTFGSGTKLEIK
230,mouse,Rivabazumab,EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYPMHWVRQAPTKGLEWVAVISYDGSEKWYADSVKGRFTISRDNAKSTLYLQMNSLRSEDTATYYCTRNRGDIYYDFTYAMDIWGQGASVTVSS,DIQMTQSPASLSVSVGETVTITCRASEGVDRWLAWYQQKQGRSPQLLIYDASTLQSGVPSRFSGSGSGTQYSLKINSLQSEDLGSYYCQHFWGTPYTFGGGTKLEIK
231,humanized,Rivabazumab,EVQLVESGGGVVQPGRSLRLSCAASGFTFSNYPMHWVRQAPGKGLEWVAVISYDGSEKWYADSVKGRFTISRDNSKNTLYLEMNSLRPEDTAVYYCARNRGDIYYDFTYAMDIWGQGTTVTVSS,DIQLTQSPSTLSASVGDSVTITCRASEGVDRWLAWYQQKPGRAPKLLIYDASTLQSGVPSRFSGSGSGTEFSLTISSLQPDDVATYYCQHFWGTPYTFGQGTKLEIK
232,mouse,Romosozumab,EVQLQQSGPELVKPGASVKIPCKASGYTFTDYNMHWVKQSHGKSLEWIGEINPNSGGAGYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYYARLGYDDIYDDWYFDVWGTGTTVTVSS,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLLSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGDTLPYTFGGGTKLEIK
233,humanized,Romosozumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIK
234,mouse,Rontalizumab,EVQLQQSGPELVKPGASVKMSCKASGYTFTEYIIHWVKQKPGQGLEWIGSINPDYDITNYNQRFKGKATLTSDKSSRTAYMELSSLTSEDSAVYYCASWISDFFDYWGQGTSVTVSS,DIVLTQSPASLAVSLGQRATISCRASQSVSTSSYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVQEEDTATYYCQHSWGIPRTFGGGTKLEIK
235,humanized,Rontalizumab,EVQLVESGGGLVQPGGSLRLSCATSGYTFTEYIIHWVRQAPGKGLEWVASINPDYDITNYNQRFKGRFTISLDKSKRTAYLQMNSLRAEDTAVYYCASWISDFFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKVLISYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWGIPRTFGQGTKVEIK
236,mouse,Rosmantuzumab,QVQLQQSGPELVKPGASVKISCKASGYTFTDYSIHWVKQRPGQGLEWIGYIYPSNGDSGYNQKFKNKATLTVDTSSSTAYMQLSSLTSEDSAVYFCATYFANNFDYWGQGTTLTVSS,DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
237,humanized,Rosmantuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYSIHWVRQAPGQGLEWIGYIYPSNGDSGYNQKFKNRVTMTRDTSTSTAYMELSRLRSEDTAVYYCATYFANNFDYWGQGTTLTVSS,DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISPVQAEDFATYYCQQSNEDPLTFGAGTKLELK
238,mouse,Rovalpituzumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDMATYFCARIGDSSPSDYWGQGTTLTVSS,SIVMTQTPKFLLVSAGDRVTISCKASQSVSNDVVWYQQKPGQSPKLLIYYASNRYTGVPDRFTGSGYGTDFTFTISTVQAEDLAVYFCQQDYTSPWTFGGGTKLEIK
239,humanized,Rovalpituzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARIGDSSPSDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCKASQSVSNDVVWYQQKPGQAPRLLIYYASNRYTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQDYTSPWTFGQGTKLEIK
240,mouse,Ruplizumab,QVQLKQSGAELVKPGASVKLSCKASGYTFTSYYMYWVKQRPGQGLEWIGEINPSNGDTNFNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCTRSDGRNDMDSWGQGTSVTVSS,DIVLTQSPASLAVSLGLRATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVEEEDTATYYCQHSWEIPPTFGGGTKLEIK
241,humanized,Ruplizumab,QVQLVQSGAEVVKPGASVKLSCKASGYIFTSYYMYWVKQAPGQGLEWIGEINPSNGDTNFNEKFKSKATLTVDKSASTAYMELSSLRSEDTAVYYCTRSDGRNDMDSWGQGTLVTVSS,DIVLTQSPATLSVSPGERATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLTISSVEPEDFATYYCQHSWEIPPTFGGGTKLEIK
242,mouse,Sacituzumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYTDDFKGRFAFSLETSVSTAYLQINNLKNEDTATYFCARGGFGSSYWYFDVWGAGSTVTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVSIAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFSGSGSGTDFTFTISSVQADDLAVYYCQQHYITPLTFGAGTKLEIK
243,humanized,Sacituzumab,QVQLQQSGSELKKPGASVKVSCKASGYTFTNYGMNWVKQAPGQGLKWMGWINTYTGEPTYTDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFCARGGFGSSYWYFDVWGQGSLVTVSS,DIQLTQSPSSLSASVGDRVSITCKASQDVSIAVAWYQQKPGKAPKLLIYSASYRYTGVPDRFSGSGSGTDFTLTISSLQPEDFAVYYCQQHYITPLTFGAGTKVEIK
244,mouse,Samalizumab,QVQLQQTGPELVKPGASVKISCKASGYSFTDYIILWVKQNHGKSLEWIGHIDPYYGSSNYNLKFKGKATLTVDQSSSTAYMQLNSLTSEDSAVYYCGRSKRDYFDYWGQGTTLTVSS,DIQMTQSPSSLSASIGERVTITCKASQDINSYLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGGGTKLEIK
245,humanized,Samalizumab,QVQLQQSGSELKKPGASVKISCKASGYSFTDYIILWVRQNPGKGLEWIGHIDPYYGSSNYNLKFKGRVTITADQSTTTAYMELSSLRSEDTAVYYCGRSKRDYFDYWGQGTTLTVSS,DIQMTQSPSSLSASIGDRVTITCKASQDINSYLSWFQQKPGKAPKLLIYRANRLVDGVPSRFSGSGSGTDYTLTISSLQPEDFAVYYCLQYDEFPYTFGGGTKLEIK
246,mouse,Sapelizumab,EVQLQESGPGLVKPSQSLSLTCTVTGHSITHDHAWSWIRQFPGEKLEWMGFISYSGITNYNPSLQGRISITRDTSKNQFFLQLNSVTTEDTATYYCARSLARTTAMDYWGEGTSVTVSS,DIQMTQTTSSLSASLRDSVTISCQASTDISSHLNWYQQKPDGTVKLLIYYGSHLLSGVPSRFSGSGSGTDYSLTISNLEQEDAATYFCGQGNRLPYTFGGGTKLEIE
247,humanized,Sapelizumab,QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSS,DIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIE
248,mouse,Satralizumab,EVQLQESGPGLVKPSQSLSLTCTVTGHSITHDHAWSWIRQFPGEKLEWMGFISYSGITNYNPSLQGRISITRDTSKNQFFLQLNSVTTEDTATYYCARSLARTTAMDYWGEGTSVTVSS,DIQMTQTTSSLSASLRDSVTISCQASTDISSHLNWYQQKPDGTVKLLIYYGSHLLSGVPSRFSGSGSGTDYSLTISNLEQEDAATYFCGQGNRLPYTFGGGTKLEIE
249,humanized,Satralizumab,QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSS,DIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIE
250,mouse,Simtuzumab,QVQLQQSGAELVRPGTSVKVSCKASGYAFTYYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSTSTAYMQLSSLTSEDTAVYFCARNWMNFDYWGQGSTLTVSS,DIVMTQAAPSLPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQKPGQSPQFLIYRMSNLASGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCMQHLEYPYTFGGGTKLEIK
251,humanized,Simtuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYAFTYYLIEWVRQAPGQGLEWIGVINPGSGGTNYNEKFKGRATITADKSTSTAYMELSSLRSEDTAVYFCARNWMNFDYWGQGTTVTVSS,DIVMTQTPLSLSVTPGQPASISCRSSKSLLHSNGNTYLYWFLQKPGQSPQFLIYRMSNLASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQHLEYPYTFGGGTKVEIK
252,mouse,Sofituzumab,EVQLKESGPGLVKPSQSLSLTCTVTGYSITNDYAWNWIRQFPGNKLEWMGYISYSGYTTYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARWTSGLDYWGQGTTLTVSS,DIQMTQSSSSLSVSLGGRVTITCKASDLIHNWLAWYQQKPGNAPRLLISGATSLETGVPSRFSGSGSGEDYTLSIISLQTEDVATYYCQQYWTTPFTFGSGTKLEIK
253,humanized,Sofituzumab,EVQLVESGGGLVQPGGSLRLSCAASGYSITNDYAWNWVRQAPGKGLEWVGYISYSGYTTYNPSLKSRFTISRDTSKNTLYLQMNSLRAEDTAVYYCARWTSGLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASDLIHNWLAWYQQKPGKAPKLLIYGATSLETGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYWTTPFTFGQGTKVEIK
254,mouse,Solanezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVSQINSVGNSTYYPDTVKGRFTISRDNAKNTLYLQLSSLKTEDTAIYYCARGDYWGQGTQVTVSS,DVVMTQSPLSLPVSLGDQTSISCRSSQSLIYSDGNAYLHWYLQKPGQSPELLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPWTFGGGTKLEIK
255,humanized,Solanezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVAQINSVGNSTYYPDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCASGDYWGQGTLVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLIYSDGNAYLHWFLQKPGQSPRLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK
256,mouse,Spartalizumab,QVQLQQPGAELVKPGASVKLSCKASGYTFTTYWMHWVKQRPGQGLEWIGNIYPGTGGSNFDEKFKNKATLTVDTSSSTAYMQLSSLTSEDSAVYYCTRWTTGTGAYWGQGTLVTVSA,DIVMTQSPSSLTVTPGEKVTLSCKSSQSLLDSGNQKNFLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDAAVYYCQNDYSYPYTFGGGTKLEIK
257,humanized,Spartalizumab,EVQLVQSGAEVKKPGESLRISCKGSGYTFTTYWMHWVRQATGQGLEWMGNIYPGTGGSNFDEKFKNRVTITADKSTSTAYMELSSLRSEDTAVYYCTRWTTGTGAYWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCKSSQSLLDSGNQKNFLTWYQQKPGQAPRLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCQNDYSYPYTFGQGTKVEIK
258,mouse,Suvizumab,QVQLQQSGAELVRPGTSVKISCKASGYTFTNSWIGWVKQRPGHGLEWIGDIYPGGGYTNYNEIFKGKATLTADTSSSTAYMQLSSLTSEDSAVYFCSRGIPGYAMDYWGQGTSVTVSS,DIVMTQRPSSLSVSAGEKVTMSCKSSQSLLNSGDQKNYLTWYQQKPGQPPKLLIYWASTGESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPWTFGGGTKLEIK
259,humanized,Suvizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNSWIGWFRQAPGQGLEWIGDIYPGGGYTNYNEIFKGKATMTADTSTNTAYMELSSLRSEDTAVYYCSRGIPGYAMDYWGQGTLVTVSS,DIQMTQRPDSLSASVGDRVTMSCKSSQSLLNSGDQKNYLTWYQQKPGQPPKLLIYWASTGESGVPDRFSGSGSGTDFTFTISSLQPEDIATYYCQNDYSYPWTFGQGTKVEIK
260,mouse,Tadocizumab,QVQLKESGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVIYPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARRDGNYGWFAYWGQGTLVTVSA,DIQMTQTTSSLSASLGDRVTISCRASQDINNYLNWYQQKPDGTVKLLIYYTSTLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEVK
261,humanized,Tadocizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYAFTNYLIEWVRQAPGQGLEWIGVIYPGSGGTNYNEKFKGRVTLTVDESTNTAYMELSSLRSEDTAVYFCARRDGNYGWFAYWGQGTLVTVSS,DIQMTQTPSTLSASVGDRVTISCRASQDINNYLNWYQQKPGKAPKLLIYYTSTLHSGVPSRFSGSGSGTDYTLTISSLQPDDFATYFCQQGNTLPWTFGQGTKVEVK
262,mouse,Talacotuzumab,EVQLQQSGPELVKPGASVKMSCKASGYTFTDYYMKWAKQSHGKSLEWIGDIIPSNGATFYNQKFKGKATLTVDKSSSTTYMQLDSLTSEDSAVYYCARSHLLRASWFAYWGQGTLVTVSA,DIVMTQSPSSLAVSAGEKVTMSCESSQSLLNSGNQKNYLTWYQQKPGQPPKPLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPYTFGGGTKLEIK
263,humanized,Talacotuzumab,EVQLVQSGAEVKKPGESLKISCKGSGYSFTDYYMKWARQMPGKGLEWMGDIIPSNGATFYNQKFKGQVTISADKSISTTYLQWSSLKASDTAMYYCARSHLLRASWFAYWGQGTMVTVSS,DIVMTQSPDSLAVSLGERATINCESSQSLLNSGNQKNYLTWYQQKPGQPPKPLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGQGTKLEIK
264,mouse,Tanezumab,QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYDLNWVRQPPGKGLEWLGIIWGDGTTDYNSAVKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARGGYWYATSYYFDYWGQGTTLTVSS,DIQMTQTTSSLSASLGDRVTISCRASQSISNNLNWYQQKPDGTVKLLIYYTSRFHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQEHTLPYTFGGGTKLEIK
265,humanized,Tanezumab,QVQLQESGPGLVKPSETLSLTCTVSGFSLIGYDLNWIRQPPGKGLEWIGIIWGDGTTDYNSAVKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCARGGYWYATSYYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISNNLNWYQQKPGKAPKLLIYYTSRFHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQEHTLPYTFGQGTKLEIK
266,mouse,Telisotuzumab,QVQLQQSGPELVKPGASVKISCKTSGYTFTAYTMHWVKQSHGKSLEWIGWIKPNNGLANYAQKFQGKATLTVDKSSSTAYMELLSLTSEDSAVYYCARSEITTEFDYWGQGTTLTVSS,DIVLTQSPASLAVSLGQRATISCKSSESVDSYANSFLHWYQQKPGQPPKLLIYRASTRESGIPARFSGSGSRTDFTLTINPVEADDVATYYCQQSKEDPLTFGAGTKLELK
267,humanized,Telisotuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYIFTAYTMHWVRQAPGQGLEWMGWIKPNNGLANYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSEITTEFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSESVDSYANSFLHWYQQKPGQPPKLLIYRASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSKEDPLTFGGGTKVEIK
268,mouse,Teplizumab,QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKVKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTPVTVSS,DIVMTQSTSSLSVSAGEKVTITCSASSSVSYMNWYQQTSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPFTFGSGTKLQIT
269,humanized,Teplizumab,QVQLVQSGGGVVQPGRSLRLSCKASGYTFTRYTMHWVRQAPGKGLEWIGYINPSRGYTNYNQKVKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFCARYYDDHYCLDYWGQGTPVTVSS,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQTPGKAPKRWIYDTSKLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSNPFTFGQGTKLQIT
270,mouse,Tibulizumab,QVQLQESGPGLVKPSETLSLTCAVSGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISTDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGVLVTVSS,QIVLTQSPATMSASPGEKVTLTCRASQSVSRYLAWYQQKPGSSPKLRIYDASNRATGVPARFSGSGSGTSSSLTISSMEAEDAASYFCQQRSNWPRTFGGGTKLEIK
271,humanized,Tibulizumab,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK
272,mouse,Tigatuzumab,EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYVMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARRGDSMITTDYWGQGTTLTVSS,DIVMTQSPKFMSTSVGDRVSITCKASQDVGTAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYRTFGGGTKLEIK
273,humanized,Tigatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIK
274,mouse,Tildrakizumab,QVQLQQSGPELVRPGASVKLSCKASGYIFITYWMTWVKQRPGQGLEWIGQIFPASGSADYNEKFEGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGGGFAYWGQGTLVTVSA,DIQMTQSPASLSAFVGETVTITCRTSENIYSYLAWYQQKQGKSPQFLVYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGIPFTFGSGTKLEIK
275,humanized,Tildrakizumab,QVQLVQSGAEVKKPGASVKVSCKASGYIFITYWMTWVRQAPGQGLEWMGQIFPASGSADYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGGGFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGIPFTFGQGTKVEIK
276,mouse,Timigutuzumab,EVKLMESGAELVKPGASVKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYADSVKGKATITADTSSNTAYLQLSSLTSEDTAVYYCSRWGGDGFYAMDYWGQGTSVTVSS,DIMMTQSHKFMSTSVGDRVSITCRASQDVNTAVAWYQQKPGHSPKLLIYSASFLYSGVPDRFTGSRSGTDFTFTINSVQAEDLAVYYCQQHYTTPPTFGGGTKLEIK
277,humanized,Timigutuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK
278,mouse,Tislelizumab,QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIYADGSTNYNPSLKSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARAYGNYWYIDVWGAGTTVTVSS,SIVMTQTPKFLLVSAGDRVTITCKSSESVSNDVAWYQQKPGQSPKLLINYAFHRFTGVPDRFTGSGYGTDFTFTISTVQAEDLAVYFCHQAYSSPYTFGGGTKLEIK
279,humanized,Tislelizumab,QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYGVHWIRQPPGKGLEWIGVIYADGSTNYNPSLKSRVTISKDTSKNQVSLKLSSVTAADTAVYYCARAYGNYWYIDVWGQGTTVTVSS,DIVMTQSPDSLAVSLGERATINCKSSESVSNDVAWYQQKPGQPPKLLINYAFHRFTGVPDRFSGSGYGTDFTLTISSLQAEDVAVYYCHQAYSSPYTFGQGTKLEIK
280,mouse,Tocilizumab,EVQLQESGPGLVKPSQSLSLTCTVTGYSITSDHAWSWIRQFPGNKLEWMGYISYSGITTYNPSLKSRISILRDTSKNQFFLQLNSVTTEDTATYYCARSLARTTAMDYWGQGSSVTVSS,DIQMTQTTSSLSASLGDRVTISCRASQDISSYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPYTFGGGTKLEIK
281,humanized,Tocilizumab,QVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIK
282,mouse,Trastuzumab,EVKLMESGAELVKPGASVKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYADSVKGKATITADTSSNTAYLQLSSLTSEDTAVYYCSRWGGDGFYAMDYWGQGTSVTVSS,DIMMTQSHKFMSTSVGDRVSITCRASQDVNTAVAWYQQKPGHSPKLLIYSASFLYSGVPDRFTGSRSGTDFTFTINSVQAEDLAVYYCQQHYTTPPTFGGGTKLEIK
283,humanized,Trastuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK
284,mouse,Tregalizumab,EEQLVETGGGLVRPGNSLKLSCVTSGFTFSDCRMYWLRQPPGKRLEWIAVISVKSENYGANYAESVRGRFTISRDDSKSSVYLQMNRLREEDTATYYCSASYYRYDVGAWFAYWGQGTLVTVSA,DIVLTQSPDSLAVSLGQRATISCRASKSVSTSGYSYIYWYQQKPGQPPKLLIYLASILESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELPWTFGGGTKLEIK
285,humanized,Tregalizumab,EEQLVESGGGLVKPGGSLRLSCAASGFSFSDCRMYWLRQAPGKGLEWIGVISVKSENYGANYAESVRGRFTISRDDSKNTVYLQMNSLKTEDTAVYYCSASYYRYDVGAWFAYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCRASKSVSTSGYSYIYWYQQKPGQPPKLLIYLASILESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQHSRELPWTFGQGTKVEIK
286,mouse,Vandortuzumab,EVQLKESGPGLVKPSQSLSLTCTVSGYSITSDYAWNWIRQFPGNKLEWMGYISNSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARERNYDYDDYYYAMDYWGQGTSVTVSS,DIVMTQSPSSLAMSVGQKVTMSCKSSQSLLYRSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYNYPRTFGGGTKLEIK
287,humanized,Vandortuzumab,EVQLVESGGGLVQPGGSLRLSCAVSGYSITSDYAWNWVRQAPGKGLEWVGYISNSGSTSYNPSLKSRFTISRDTSKNTLYLQMNSLRAEDTAVYYCARERNYDYDDYYYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKSSQSLLYRSNQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYNYPRTFGQGTKVEIK
288,mouse,Vatelizumab,QVQLQESGPGLVAPSQSLSITCTVSGFSLTNYGIHWVRQPPGKGLEWLGVIWARGFTNYNSALMSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARANDGVYYAMDYWGQGTSVTVSS,DFVMTQSPAIMSASPGEKVTITCSAQSSVNYIHWYQQKSDTSPKKWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWTTNPLTFGAGTKLELK
289,humanized,Vatelizumab,QVQLQESGPGLVKPSETLSLTCTVSGFSLTNYGIHWIRQPPGKGLEWLGVIWARGFTNYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYCARANDGVYYAMDYWGQGTLVTVSS,DFVMTQSPAFLSVTPGEKVTITCSAQSSVNYIHWYQQKPDQAPKKLIYDTSKLASGVPSRFSGSGSGTDYTFTISSLEAEDAATYYCQQWTTNPLTFGQGTKVEIK
290,mouse,Vedolizumab,QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGEIDPSESNTNYNQKFKGKATLTVDISSSTAYMQLSSLTSEDSAVYYCARGGYDGWDYAIDYWGQGTSVTVSS,DVVVTQTPLSLPVSFGDQVSISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISTIKPEDLGMYYCLQGTHQPYTFGGGTKLEIK
291,humanized,Vedolizumab,QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLEWIGEIDPSESNTNYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDGWDYAIDYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHQPYTFGQGTKVEIK
292,mouse,Veltuzumab,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAFYYCARSTYYGGDWYFDVWGAGTTVTVSS,DIVLTQSPAILSASPGEKVTMTCRASSSVSYIHWYQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWTSNPPTFGGGTKLEIK
293,humanized,Veltuzumab,QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIK
294,mouse,Visilizumab,QVQLQQSGAELAKPGASVKLSCKASGYTFTSYTMHWVKQRPGQGLEWIGYINPRSGYTHYNQKLKDKATLTADKSSSTAYMQLSSLTYEDSAVYYCARSAYYDYDGFAYWGQGTLVTVSA,DIVLTQTPSSLSASLGDRVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPPTFGGGTKLEIK
295,humanized,Visilizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLEWMGYINPRSGYTHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCARSAYYDYDGFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRLIYDTSKLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSSNPPTFGGGTKVEIK
296,mouse,Vonlerolizumab,ELQLKESGPELVEPGASMKMSCKASGYTFTDSYMSGVRQSHGKSLEWIGDMYPDNGDSSYNQKFREKATLTVDRSSSTAYMQLDSLTSEDSAAHYCVLAPRWYFSVWGAGTTVTVSS,DIQMTQTPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLRSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGHTLPPTFGGGTKLEIK
297,humanized,Vonlerolizumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDSYMSWVRQAPGQGLEWIGDMYPDNGDSSYNQKFRERVTITRDTSTSTAYLELSSLRSEDTAVYYCVLAPRWYFSVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLRSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGHTLPPTFGQGTKVEIK
298,mouse,Vorsetuzumab,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADAFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARDYGDYGMDYWGQGTSVTVSS,DIVLTQSPDSLAVSLGQRATISCRASKSVSTSGYSFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSREVPWTFGGGTKLEIK
299,humanized,Vorsetuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLKWMGWINTYTGEPTYADAFKGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARDYGDYGMDYWGQGTTVTVSS,DIVMTQSPDSLAVSLGERATINCRASKSVSTSGYSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQHSREVPWTFGQGTKVEIK
300,mouse,Vunakizumab,EVQVVESGAELVRPGASVTLSCKASGYTFTDYEVHWVKQTPVHGLEWIGVIDPGTGGVAYNQKFEGKAILTADKSSSPAYLELRSLTSEDSAVYYCTRYSLFYGSSPYAMDYWGQGTSVTVSS,EIVITQTTAIQSASPKEKVTITCSASSSVNYMHWYQQKSDASPKPWIYRTSNLASGVPARFSGSGSGTSYSLTISRMEAEDAATYYCQQRSSYPWTFGGGTKLEIK
301,humanized,Vunakizumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYEVHWVRQAPGQGLEWMGVIDPGTGGVAYNQKFEGRVTMTADTSTSTAYMELRSLRSDDTAVYYCTRYSLFYGSSPYAMDYWGQGTLVTVSS,EIVLTQSPDFQSVTPKEKVTITCSASSSVNYMHWFQQKPDQSPKLWIYRTSNLASGVPSRFSGSGSGTDYTLTINSLEAEDAATYYCQQRSSYPWTFGQGTKLEIK
302,mouse,Zenocutuzumab,EVQLQQSGPELVKPGASVKISCKASGYTFTGYYMHWVKQSHGKSLEWIGWINPNSGGTNYAQKFQGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARDHGSRHFWSYWGFDYWGTGTTVTVSS,DIVLTQSPATLSVTPGDRVSLSCRASQSISSYLNWYQQKSHESPRLLIKAASSLQSGIPSRFSGSGSGTDFTLSINSVETEDFGMYFCQQSYSTPPTFGAGTKLELK
303,humanized,Zenocutuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARDHGSRHFWSYWGFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVEIK
